Big News for British Columbians Living with Diabetes: What the New PharmaCare April 1 Coverage Means for You
- t2diabetesnetwork
- 3 days ago
- 4 min read
Written by Clare Koning, RN, PhD
T2D Network | April 1, 2026 | 5 min read
Key Highlights:
✅ Lancets, alcohol swabs, and ketone strips now covered under PharmaCare
✅ A hybrid closed-loop insulin pump covered for eligible people with Type 1 diabetes
✅ People on Plans C, F, and W receive 100% coverage at no cost
✅ Funded via National Pharmacare agreement: up to $670 million over three years
✅ Register for Fair PharmaCare to access income-based coverage
If you've been managing diabetes in British Columbia, today is a day worth marking on your calendar. As of April 1, 2026, the province has expanded PharmaCare coverage for a range of diabetes-related supplies and devices, changes that could save you anywhere from a few hundred to several thousand dollars a year.
This builds on coverage announced earlier this year for a wide range of diabetes medications, including many insulins, Metformin, and newer agents like Dapagliflozin and Empagliflozin. Today's update goes a step further, bringing everyday testing supplies and advanced insulin delivery technology into the coverage fold.
Here's what you need to know.
What's Newly Covered?
Everyday Testing Supplies
Managing blood sugar at home requires tools. And for many people with diabetes, those tools come with a monthly price tag that adds up fast.
Starting today April 1, 2026, more British Columbians are eligible for PharmaCare coverage of:
Lancets (up to 400 per year)
Alcohol swabs (up to 300 per year)
Blood or urine ketone strips (up to 100 per year)
These three items together form the core of an at-home diabetes testing kit. Depending on the brands you use and how often you test, this could represent savings of $30 to $100 every month.
Coverage is processed directly at your pharmacy counter. You'll just need to present your B.C. Services Card.
Important: To be eligible, you must have received training from a diabetes education centre or primary care network, the same requirement that applies to blood-glucose test strips. If you haven't connected with a diabetes education program yet, this is a great reason to do so.
A Hybrid Closed-Loop Insulin Pump – A First for PharmaCare
This one is a game-changer for people with Type 1 diabetes who meet certain clinical criteria.
The Ypsomed mylife Ypsopump is now the first hybrid closed-loop (HCL) insulin delivery system to receive PharmaCare coverage in B.C. When paired with the Dexcom G6 continuous glucose monitor and a compatible smartphone app, it creates a system that continuously monitors glucose levels and automatically adjusts insulin delivery in real time.
For those who qualify, PharmaCare will cover up to $7,000 for the pump (which carries a five-year warranty). Other HCL technologies are currently under review.
Dr. Tom Elliott, medical director of B.C. Diabetes, called it "great news" while framing it as one step toward the best possible care for people living with diabetes in B.C., and we agree. Automated insulin delivery technology has the potential to reduce the cognitive load of constant glucose monitoring and improve time-in-range outcomes significantly.
Who Is Covered and How?
Coverage flows through existing PharmaCare plans:
Plan | Who It Covers | Coverage Level |
Plan C | Income Assistance and Family Services recipients | 100% |
Plan F | Children in the At-Home Program | 100% |
Plan W | First Nations Health Authority members | 100% |
Plan B | Long-term Care residents (pump only) | 100% |
Fair PharmaCare | All other B.C. residents | Based on family income |
If you're not currently enrolled in Plan C, F, or W, registering for Fair PharmaCare is the key step. It's free to sign up, and your coverage level is determined by your household income, meaning lower-income families pay less.
Why This Matters
Living with diabetes is expensive. Test strips, lancets, swabs, and devices quietly drain household budgets, and for people managing diabetes on a fixed income or dealing with other financial pressures, these costs can lead to rationing supplies or skipping tests altogether. That has real consequences for blood sugar control, and downstream, for long-term complications.
Federal Health Minister Marjorie Michel acknowledged this directly: "Many British Columbians are feeling the pressure of daily expenses, including the high cost of managing chronic diseases like diabetes."
This expanded coverage, funded through the federal-provincial National Pharmacare agreement signed in March 2025, which provides up to $670 million over three years (including approximately $37 million specifically for diabetes devices and supplies), is a meaningful step toward reducing that burden.
What Should You Do Next?
Here's a quick action list:
Check your PharmaCare plan. Log in at gov.bc.ca/nationalpharmacare or call your pharmacy to confirm your coverage.
Register for Fair PharmaCare if you're not on Plan C, F, or W. Registration is based on your most recent tax return and takes only a few minutes online.
Talk to your diabetes care team. If you haven't received training at a diabetes education centre or primary care network, you'll need to do so before claiming lancets, swabs, or ketone strips.
Ask your endocrinologist or diabetes specialist whether you meet the clinical criteria for the Ypsopump if you have Type 1 diabetes.
Bring your B.C. Services Card to the pharmacy. Coverage is applied at the counter.
The Bigger Picture
This coverage expansion is part of a broader shift in how Canada is approaching diabetes care. Since March 1, 2026, hundreds of thousands of British Columbians have already gained access, at no cost, to menopausal hormone therapy, contraceptives, and a suite of diabetes medications under the National Pharmacare Plan (Plan NP).
Today's announcement adds supplies and devices to that list, moving care beyond the prescription pad and toward the full toolkit that people actually use every day.
There's still work to be done, access to diabetes education, equitable coverage of CGM technology, and support for underserved communities remain ongoing priorities. But as
Dr. Elliott noted, today is a step in the right direction.
We'll be watching for further updates as additional HCL systems and devices are reviewed for coverage. Stay connected with the T2D Network for the latest news, resources, and community support.
For more information, visit gov.bc.ca/nationalpharmacare and https://news.gov.bc.ca/releases/2026HLTH0030-000334 or speak with your healthcare provider or pharmacist.
